軟部肉腫は、筋肉、腱、脂肪、神経、血管、結合組織などの体の軟部組織に発生するがんの一種です。体の軟部組織にしこりや腫れがある場合は、軟部肉腫の兆候です。軟部肉腫が発生する部位は体内の様々な場所にあり、生検によって特定されます。世界市場の成長は、新規治療法の採用の増加、個別化医療への注目の高まり、人口の増加、医療費の増加などの要因に加え、有利な償還政策が牽引しています。
また、がんの発生件数の増加が、世界の市場成長の触媒として作用しています。世界保健機関（WHO）によると、2020年には世界で約1,930万件の新たながん患者が記録されたと推定されており、今後も増加して、2040年には3,030万件に達する可能性が高いと予測されています。したがって、これらの要因が、予測期間中の軟部肉腫市場の成長を促進しています。さらに、診断や治療法の進歩、研究開発への投資の増加は、予測期間中にさまざまな有利な機会をもたらしています。しかし、治療費の高さと軟部肉腫治療薬の副作用が、2023年から2030年の予測期間を通じて市場成長を妨げています。
軟部肉腫の世界市場調査において考慮された主要地域は、アジア太平洋、北アメリカ、ヨーロッパ、ラテンアメリカ、中東・アフリカです。北アメリカは、標的治療への需要の急増、個別化医療への注目の高まり、確立されたヘルスケア施設の存在により、2022年の市場を独占しました。一方、アジア太平洋は、軟部肉腫の有病率の上昇、医療費の増加、研究開発への投資の増加などの要因から、予測期間中に最も高いCAGRで成長すると予想されます。
本調査の目的は、近年における様々なセグメント・国の市場規模を定義し、今後数年間の価値を予測することです。本レポートは、調査対象国における産業の質的・量的な側面を取り込むように設計されています。
さらに、市場の今後の成長を決定づける推進要因や課題などの重要な側面に関する詳細情報も提供しています。さらに、主要企業の競争環境と製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場の潜在的な機会も組み込んでいます。
目次
Table of Contents
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. Soft Tissue Sarcoma Market, by Region, 2020-2030 (USD Billion)
1.2.2. Soft Tissue Sarcoma Market, by Treatment, 2020-2030 (USD Billion)
1.2.3. Soft Tissue Sarcoma Market, by Route of Administration, 2020-2030 (USD Billion)
1.2.4. Soft Tissue Sarcoma Market, by End-users, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Soft Tissue Sarcoma Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Soft Tissue Sarcoma Market Dynamics
3.1. Soft Tissue Sarcoma Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Rising adoption of novel therapies
3.1.1.2. Surge in the incidences of cancer
3.1.2. Market Challenges
3.1.2.1. High cost of treatments
3.1.2.2. Side effects of soft tissue sarcoma drugs
3.1.3. Market Opportunities
3.1.3.1. Rising advancements in diagnostics and treatment options
3.1.3.2. Increasing investments in research and development
Chapter 4. Global Soft Tissue Sarcoma Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter's 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
Chapter 5. Global Soft Tissue Sarcoma Market, by Treatment
5.1. Market Snapshot
5.2. Global Soft Tissue Sarcoma Market by Treatment, Performance - Potential Analysis
5.3. Global Soft Tissue Sarcoma Market Estimates & Forecasts by Treatment 2020-2030 (USD Billion)
5.4. Soft Tissue Sarcoma Market, Sub Segment Analysis
5.4.1. Targeted Therapy
5.4.2. Chemotherapy
5.4.3. Anti-Angiogenesis Drugs
5.4.4. Radiation Therapy
Chapter 6. Global Soft Tissue Sarcoma Market, by Route of Administration
6.1. Market Snapshot
6.2. Global Soft Tissue Sarcoma Market by Route of Administration, Performance - Potential Analysis
6.3. Global Soft Tissue Sarcoma Market Estimates & Forecasts by Route of Administration 2020-2030 (USD Billion)
6.4. Soft Tissue Sarcoma Market, Sub Segment Analysis
6.4.1. Oral
6.4.2. Parenteral
6.4.3. Others
Chapter 7. Global Soft Tissue Sarcoma Market, by End-users
7.1. Market Snapshot
7.2. Global Soft Tissue Sarcoma Market by End-users, Performance - Potential Analysis
7.3. Global Soft Tissue Sarcoma Market Estimates & Forecasts by End-users 2020-2030 (USD Billion)
7.4. Soft Tissue Sarcoma Market, Sub Segment Analysis
7.4.1. Hospitals
7.4.2. Homecare
7.4.3. Speciality Centres
7.4.4. Others
Chapter 8. Global Soft Tissue Sarcoma Market, Regional Analysis
8.1. Top Leading Countries
8.2. Top Emerging Countries
8.3. Soft Tissue Sarcoma Market, Regional Market Snapshot
8.4. North America Soft Tissue Sarcoma Market
8.4.1. U.S. Soft Tissue Sarcoma Market
8.4.1.1. Treatment breakdown estimates & forecasts, 2020-2030
8.4.1.2. Route of Administration breakdown estimates & forecasts, 2020-2030
8.4.1.3. End-users breakdown estimates & forecasts, 2020-2030
8.4.2. Canada Soft Tissue Sarcoma Market
8.5. Europe Soft Tissue Sarcoma Market Snapshot
8.5.1. U.K. Soft Tissue Sarcoma Market
8.5.2. Germany Soft Tissue Sarcoma Market
8.5.3. France Soft Tissue Sarcoma Market
8.5.4. Spain Soft Tissue Sarcoma Market
8.5.5. Italy Soft Tissue Sarcoma Market
8.5.6. Rest of Europe Soft Tissue Sarcoma Market
8.6. Asia-Pacific Soft Tissue Sarcoma Market Snapshot
8.6.1. China Soft Tissue Sarcoma Market
8.6.2. India Soft Tissue Sarcoma Market
8.6.3. Japan Soft Tissue Sarcoma Market
8.6.4. Australia Soft Tissue Sarcoma Market
8.6.5. South Korea Soft Tissue Sarcoma Market
8.6.6. Rest of Asia Pacific Soft Tissue Sarcoma Market
8.7. Latin America Soft Tissue Sarcoma Market Snapshot
8.7.1. Brazil Soft Tissue Sarcoma Market
8.7.2. Mexico Soft Tissue Sarcoma Market
8.8. Middle East & Africa Soft Tissue Sarcoma Market
8.8.1. Saudi Arabia Soft Tissue Sarcoma Market
8.8.2. South Africa Soft Tissue Sarcoma Market
8.8.3. Rest of Middle East & Africa Soft Tissue Sarcoma Market
Chapter 9. Competitive Intelligence
9.1. Key Company SWOT Analysis
9.1.1. Company 1
9.1.2. Company 2
9.1.3. Company 3
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. F. Hoffmann-La Roche Ltd. (Switzerland)
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Recent Developments
9.3.2. Mylan N.V. (U.S.)
9.3.3. Teva Pharmaceutical Industries Ltd. (Israel)
9.3.4. Sanofi (France)
9.3.5. Pfizer Inc. (U.S.)
9.3.6. GSK plc (U.K.)
9.3.7. Novartis AG (Switzerland)
9.3.8. Bayer AG (Germany)
9.3.9. Merck & Co., Inc. (U.S.)
9.3.10. Sun Pharmaceutical Industries Ltd. (India)
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption
LIST OF TABLES
TABLE 1. Global Soft Tissue Sarcoma Market, report scope
TABLE 2. Global Soft Tissue Sarcoma Market estimates & forecasts by Region 2020-2030 (USD Billion)
TABLE 3. Global Soft Tissue Sarcoma Market estimates & forecasts by Treatment 2020-2030 (USD Billion)
TABLE 4. Global Soft Tissue Sarcoma Market estimates & forecasts by Route of Administration 2020-2030 (USD Billion)
TABLE 5. Global Soft Tissue Sarcoma Market estimates & forecasts by End-users 2020-2030 (USD Billion)
TABLE 6. Global Soft Tissue Sarcoma Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 7. Global Soft Tissue Sarcoma Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 8. Global Soft Tissue Sarcoma Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 9. Global Soft Tissue Sarcoma Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 10. Global Soft Tissue Sarcoma Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 11. Global Soft Tissue Sarcoma Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 12. Global Soft Tissue Sarcoma Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 13. Global Soft Tissue Sarcoma Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 14. Global Soft Tissue Sarcoma Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 15. Global Soft Tissue Sarcoma Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 16. U.S. Soft Tissue Sarcoma Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 17. U.S. Soft Tissue Sarcoma Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 18. U.S. Soft Tissue Sarcoma Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 19. Canada Soft Tissue Sarcoma Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 20. Canada Soft Tissue Sarcoma Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 21. Canada Soft Tissue Sarcoma Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 22. UK Soft Tissue Sarcoma Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 23. UK Soft Tissue Sarcoma Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 24. UK Soft Tissue Sarcoma Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 25. Germany Soft Tissue Sarcoma Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 26. Germany Soft Tissue Sarcoma Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 27. Germany Soft Tissue Sarcoma Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 28. France Soft Tissue Sarcoma Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 29. France Soft Tissue Sarcoma Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 30. France Soft Tissue Sarcoma Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 31. Italy Soft Tissue Sarcoma Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 32. Italy Soft Tissue Sarcoma Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 33. Italy Soft Tissue Sarcoma Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 34. Spain Soft Tissue Sarcoma Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 35. Spain Soft Tissue Sarcoma Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 36. Spain Soft Tissue Sarcoma Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 37. RoE Soft Tissue Sarcoma Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 38. RoE Soft Tissue Sarcoma Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 39. RoE Soft Tissue Sarcoma Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 40. China Soft Tissue Sarcoma Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 41. China Soft Tissue Sarcoma Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 42. China Soft Tissue Sarcoma Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 43. India Soft Tissue Sarcoma Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 44. India Soft Tissue Sarcoma Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 45. India Soft Tissue Sarcoma Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 46. Japan Soft Tissue Sarcoma Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 47. Japan Soft Tissue Sarcoma Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 48. Japan Soft Tissue Sarcoma Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 49. South Korea Soft Tissue Sarcoma Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 50. South Korea Soft Tissue Sarcoma Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 51. South Korea Soft Tissue Sarcoma Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 52. Australia Soft Tissue Sarcoma Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 53. Australia Soft Tissue Sarcoma Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 54. Australia Soft Tissue Sarcoma Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 55. RoAPAC Soft Tissue Sarcoma Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 56. RoAPAC Soft Tissue Sarcoma Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 57. RoAPAC Soft Tissue Sarcoma Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 58. Brazil Soft Tissue Sarcoma Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 59. Brazil Soft Tissue Sarcoma Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 60. Brazil Soft Tissue Sarcoma Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 61. Mexico Soft Tissue Sarcoma Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 62. Mexico Soft Tissue Sarcoma Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 63. Mexico Soft Tissue Sarcoma Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 64. RoLA Soft Tissue Sarcoma Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 65. RoLA Soft Tissue Sarcoma Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 66. RoLA Soft Tissue Sarcoma Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 67. Saudi Arabia Soft Tissue Sarcoma Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 68. South Africa Soft Tissue Sarcoma Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 69. RoMEA Soft Tissue Sarcoma Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 70. List of secondary sources, used in the study of global Soft Tissue Sarcoma Market
TABLE 71. List of primary sources, used in the study of global Soft Tissue Sarcoma Market
TABLE 72. Years considered for the study
TABLE 73. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
LIST OF FIGURES
FIG 1. Global Soft Tissue Sarcoma Market, research methodology
FIG 2. Global Soft Tissue Sarcoma Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Soft Tissue Sarcoma Market, key trends 2022
FIG 5. Global Soft Tissue Sarcoma Market, growth prospects 2023-2030
FIG 6. Global Soft Tissue Sarcoma Market, porters 5 force model
FIG 7. Global Soft Tissue Sarcoma Market, pest analysis
FIG 8. Global Soft Tissue Sarcoma Market, value chain analysis
FIG 9. Global Soft Tissue Sarcoma Market by segment, 2020 & 2030 (USD Billion)
FIG 10. Global Soft Tissue Sarcoma Market by segment, 2020 & 2030 (USD Billion)
FIG 11. Global Soft Tissue Sarcoma Market by segment, 2020 & 2030 (USD Billion)
FIG 12. Global Soft Tissue Sarcoma Market by segment, 2020 & 2030 (USD Billion)
FIG 13. Global Soft Tissue Sarcoma Market by segment, 2020 & 2030 (USD Billion)
FIG 14. Global Soft Tissue Sarcoma Market, regional snapshot 2020 & 2030
FIG 15. North America Soft Tissue Sarcoma Market 2020 & 2030 (USD Billion)
FIG 16. Europe Soft Tissue Sarcoma Market 2020 & 2030 (USD Billion)
FIG 17. Asia pacific Soft Tissue Sarcoma Market 2020 & 2030 (USD Billion)
FIG 18. Latin America Soft Tissue Sarcoma Market 2020 & 2030 (USD Billion)
FIG 19. Middle East & Africa Soft Tissue Sarcoma Market 2020 & 2030 (USD Billion)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
